MYND Life Sciences Ratios and Metrics

Market cap in millions CAD. Fiscal year is November - October.

Millions CAD. Fiscal year is Nov - Oct.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 26, 2024	Oct '23 Oct 31, 2023	Oct '22 Oct 31, 2022	Oct '21 Oct 31, 2021	Oct '20 Oct 31, 2020	Oct '19 Oct 31, 2019
Market Capitalization	2	1	4	45	-	-
Market Cap Growth	19.16%	-80.85%	-91.76%	-	-	-
Enterprise Value	5	4	6	46	-	-
Last Close Price	0.04	0.01	0.08	0.99	-	-
PE Ratio	-	-0.47	-1.05	-10.19	-	-
PB Ratio	-0.30	-0.14	-1.06	-669.05	-	-
P/FCF Ratio	-7.48	-3.62	-2.06	-15.03	-	-
P/OCF Ratio	-7.53	-3.62	-2.06	-15.25	-	-
EV/EBITDA Ratio	-3.72	-2.02	-2.03	-10.67	-	-
EV/EBIT Ratio	-3.71	-2.02	-2.03	-10.65	-	-
EV/FCF Ratio	-20.89	-18.59	-3.42	-15.10	-	-
Debt / Equity Ratio	-0.53	-0.60	-0.73	-34.18	-	-
Debt / FCF Ratio	-13.41	-15.13	-1.42	-0.77	-	-
Quick Ratio	0.11	0.13	0.03	5.63	-	-
Current Ratio	0.11	0.14	0.06	5.76	-	-
Return on Assets (ROA)	-147.79%	-157.47%	-115.18%	-200.88%	-	-
Return on Capital (ROIC)	-	-	-292.44%	-243.66%	-	-
Earnings Yield	-41.95%	-211.62%	-95.25%	-9.60%	-	-
FCF Yield	-13.36%	-27.64%	-48.58%	-6.65%	-	-
Buyback Yield / Dilution	-1.27%	-1.27%	-3.83%	-59.27%	-1554.82%	-
Total Shareholder Return	-1.27%	-1.27%	-3.83%	-59.27%	-1554.82%	-

Source: S&P Capital IQ. Standard template. Financial Sources.